Search Results - "Kyvernitakis, A."

Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis by Kyvernitakis, A., Torres, H.A., Jiang, Y., Chamilos, G., Lewis, R.E., Kontoyiannis, D.P.

“…In view of the poor outcomes associated with mucormycosis in patients with haematologic malignancies (HM) and haematopoietic cell transplant recipients,…”
Get full text

Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation by Farmakiotis, Dimitrios, Kyvernitakis, A., Tarrand, J.J., Kontoyiannis, D.P.

“…In patients with malignancies, Candida glabrata is one of the most frequent non-albicans Candida clinical isolates. As antifungal resistance in C. glabrata is…”
Get full text

Concomitant use of direct‐acting antivirals and chemotherapy in hepatitis C virus‐infected patients with cancer by Economides, M. P., Mahale, P., Kyvernitakis, A., Turturro, F., Kantarjian, H., Naing, A., Hosry, J., Shigle, T. L., Kaseb, A., Torres, H. A.

“…Summary Background Antiviral therapy improves hepatic outcomes in hepatitis C virus (HCV)‐infected cancer patients. However, such patients are not treated…”
Get full text

Efficacy and safety of antiretrovirals in HIV-infected patients with cancer by Torres, H.A., Rallapalli, V., Saxena, A., Granwehr, B.P., Viola, G.M., Ariza-Heredia, E., Adachi, J.A., Chemaly, R.F., Marfatia, R., Jiang, Y., Mahale, P., Kyvernitakis, A., Fanale, M.A., Mulanovich, V.

“…At 30 years into the HIV infection epidemic, the optimal antiretroviral (ARV) regimen for infected patients with cancer remains unknown. We therefore sought to…”
Get full text

Sofosbuvir-based therapy in patients with chronic hepatitis C virus infection and malignancies – A prospective observational study of 136 patients by Torres, H.A, Economides, M.P, Kyvernitakis, A, Mahale, P, Hosry, J, Jiang, Y, Kaseb, A, Raad, I, Granwehr, B.P

Get full text

Bloodstream Infections in Continuous Flow Left Ventricular Assist Device Recipients: The Utility of Systemic Inflammatory Response Syndrome for Diagnosing Sepsis and Prediction of Mortality by Kyvernitakis, A, Pappas, O, Wani, A, Farmakiotis, D, Horn, E.T, Murali, S, Benza, R.L, Bailey, S.H, Agarwal, R

Get full text

Predicting Cardiac Structural and Functional Improvement Induced by Mechanical Unloading in Chronic Heart Failure: A Derivation-Validation Multicenter Study by Taleb, I., Wever-Pinzon, O., Yin, M., Kfoury, A., Caine, W., Stehlik, J., Catino, A., Wever-Pinzon, J., Bonios, M., McKellar, S., Alharethi, R., Koliopoulou, A., Fang, J., Selzman, C., Dranow, E., Shah, P., Singh, R., Psotka, M., Zhu, W., Slaughter, M., Birks, E., Koenig, S., Kanwar, M., Kyvernitakis, A., Hoffman, K., Guglin, M., Kotter, J., Campbell, K., Drakos, S.

“…Predicting cardiac structural and functional improvement in advanced heart failure (HF) patients before durable left ventricular assist device (LVAD)…”
Get full text

Trends of vaginal birth after cesarean delivery in Germany from 1990 to 2012: a population-based study by Kyvernitakis, I, Reichelt, J, Kyvernitakis, A, Misselwitz, B, Hadji, P, Schmidt, S, Kalder, M

“…The increasing incidence of cesarean deliveries (CD) in the western world is consequently leading to a rising number of antenatal counselling of pregnant women…”
Get more information

Rising cesarean rates of twin deliveries in Germany from 1990 to 2012 by Kyvernitakis, A, Kyvernitakis, I, Karageorgiadis, A S, Misselwitz, B, Papaspyrou, G, Kalder, M, Schmidt, S

“…In the past 2 decades there has been an increasing trend for cesarean deliveries in twin pregnancies associated with increased maternal and fetal morbidity and…”
Get more information

Why Defining The Anatomy Is Important: CT Coronary Angiogram Following An Abnormal Spect Identifies An Unexpected Finding by Alhuneafat, L., Kyvernitakis, A., Katchi, F.

Get full text

(941) - Clinical Experience and Outcomes of HeartMate II to HeartWare Left Ventricular Assist Device Exchange: A Multicenter Experience of 24 Cases by Agarwal, R., Kyvernitakis, A., Soleimani, B., Milano, C.A., Kennedy, J., Benza, R.L., Murali, S., Bailey, S.H.

Get full text

(322) - Bloodstream Infections in Left Ventricular Assist Device Recipients Awaiting Transplantation by Kyvernitakis, A., Pappas, O., Farmakiotis, D., Horn, E.T., Benza, R.L., Bailey, S.H., Agarwal, R.

Get full text

(215) Multicenter Development and Validation of a Machine Learning Model to Predict Myocardial Recovery During LVAD Support: The UCAR Score by Kyriakopoulos, C.P., Taleb, I., Wever-Pinzon, O., Selzman, C., Bonios, M., Dranow, E., Wever-Pinzon, J., Yin, M., Tseliou, E., Stehlik, J., Alharethi, R., Kfoury, A., Hanff, T., Fang, J., Koliopoulou, A., Sideris, K., Krauspe, E., Nelson, M., Elmer, A., Singh, R., Psotka, M., Birks, E., Slaughter, M., Koenig, S., Kyvernitakis, A., Hoffman, K., Guglin, M., Kotter, J., Campbell, K., Silvestry, S., Vidic, A., Raval, N., Mehra, M., Cowger, J., Kanwar, M., Shah, P., Drakos, S.G.

“…Although significant cardiac reverse remodeling is a prerequisite for a left ventricular (LV) assist device (LVAD) patient to be considered for device weaning,…”
Get full text

Multicenter-Derived Clinical Score Predicts Structural and Functional Cardiac Improvement in Chronic Heart Failure Patients Undergoing Mechanical Circulatory Support by Kyriakopoulos, C.P., Taleb, I., Wever-Pinzon, O., Selzman, C.H., Kfoury, A., Tseliou, E., Stehlik, J., Alharethi, R., Fang, J.C., Catino, A., Koliopoulou, A., Goodwin, M., Kagawa, H., Dranow, E., Singh, R., Psotka, M., Birks, E., Slaughter, M.S., Koenig, S., Kyvernitakis, A., Hoffman, K., Guglin, M., Kotter, J., Vidic, A., Silvestry, S., Raval, N., Kanwar, M., Shah, P., Drakos, S.G.

“…Although significant reverse cardiac remodeling is required for an LVAD-supported patient to be considered for device weaning, multiple factors including…”
Get full text

Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation: Mycology by Farmakiotis, Dimitrios, Kyvernitakis, A, Tarrand, J J, Kontoyiannis, D P

“…In patients with malignancies, Candida glabrata is one of the most frequent non-albicans Candida clinical isolates. As antifungal resistance in C. glabrata is…”
Get full text

FRI-218 - Sofosbuvir-based therapy in patients with chronic hepatitis C virus infection and malignancies – A prospective observational study of 136 patients by Torres, H.A., Economides, M.P., Kyvernitakis, A., Mahale, P., Hosry, J., Jiang, Y., Kaseb, A., Raad, I., Granwehr, B.P.

Get full text

Sustained Virologic Response After 6 Weeks of Therapy With a First-Generation Hepatitis C Virus Protease Inhibitor by Kyvernitakis, Andreas, Jabbour, Elias, Torres, Harrys A.

Get full text